Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study

Hellenic Journal of Cardiology

Volumn 55, Issue 3, 2014, Pages 217-226

  Elisaf, Moses ^a   Tzouvelekis, Emmanouil ^b   Nikas, Nikos ^b  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Crosssectional study; Guidelines; Risk factors; Treatment goals attainment

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; FRAMINGHAM RISK SCORE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OBESITY; PHYSICIAN ATTITUDE; PRIMARY PREVENTION; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SMOKING; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84901490661     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. British Heart Foundation. European Cardiovascular Disease Statistics, B.H. Foundation, Editor. 2005, British Heart Foundation: London, UK.
2. Allender S, et al. European cardiovascular disease statistics 2008. In: European Cardiovascular Disease Statistics. 2008, University of Oxford: Oxford.
3. Rayner M, Allender S, Scarborough P. Cardiovascular disease in Europe. Eur J Cardiovasc Prev Rehabil. 2009; 16 Suppl 2: S43-47.
4. Cífková R, Skodová Z. [Longitudinal trends in major cardiovascular disease risk factors in the Czech population]. Cas Lek Cesk. 2004; 143: 219-226.
5. Firmann M, Marques-Vidal P, Paccaud F, et al. Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go. Eur J Cardiovasc Prev Rehabil. 2010; 17: 682-687.
6. Müller-Riemenschneider F, Nocon M, Willich SN. Prevalence of modifiable cardiovascular risk factors in German adolescents. Eur J Cardiovasc Prev Rehabil. 2010; 17: 204-210.
7. van der Wilk EA, Jansen J. Lifestyle-related risks: are trends in Europe converging? Public Health. 2005; 119: 55-66.
8. Van Diepen S, Scholten AM, Korobili C, et al. Greater Mediterranean diet adherence is observed in Dutch compared with Greek university students. Nutr Metab Cardiovasc Dis. 2011; 21: 534-540.
9. Chimonas T, Fanouraki I, Liberopoulos EN, Chimonas E, Elisaf M. Diverging trends in cardiovascular morbidity and mortality in a low risk population. Eur J Epidemiol. 2009; 24: 415-423.
10. Kontogianni MD, Vidra N, Farmaki AE, et al. Adherence rates to the Mediterranean diet are low in a representative sample of Greek children and adolescents. J Nutr. 2008; 138: 1951-1956.
11. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas I, Stefanadis C. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study. Vasc Med. 2008; 13: 113-121.
12. Mihas C, Mariolis A, Manios Y, et al. Overweight/obesity and factors associated with body mass index during adolescence: the VYRONAS study. Acta Paediatr. 2009; 98: 495-500.
13. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. Renal function, cardiovascular disease risk factors' prevalence and 5-year disease incidence; the role of diet, exercise, lipids and inflammation markers: the ATTICA study. QJM. 2010; 103: 413-422.
14. Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil. 2009; 16: 333-350.
15. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas I, Stefanadis C. Prevalence and five-year incidence (2001-2006) of cardiovascular disease risk factors in a Greek sample: the ATTICA study. Hellenic J Cardiol. 2009; 50: 388-395.
16. Alberts MJ, Bhatt DL, Mas JL, et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J. 2009; 30: 2318-2326.
17. Esmatjes E, Blanco AJ. [The REACH registry: baseline and 1-year results]. Med Clin (Barc). 2009; 132 Suppl 2: 5-9.
18. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010; 17: 530-540.
19. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006; 295: 180-189.
20. Hermans MP, Castro Cabezas M, Strandberg T, et al. Cen tralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries. Curr Med Res Opin. 2010; 26: 445-454.
21. Elisaf MS, Nikas N. Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs-the CEPHEUS-Greece survey. Angiology. 2010; 61: 465-474.
22. Eaton CB, McQuade W, Glupczynski D. A comparison of primary versus secondary cardiovascular disease prevention in an academic family practice. Fam Med. 1994; 26: 587-592.
23. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004; 19: 638-645.
24. Perreault S, Dragomir A, Blais L, et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009; 65: 1013-1024.
25. Rodriguez-Artalejo, F, Guallar E, Borghi C, et al. Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). BMC Public Health. 2010; 10: 382.
26. Banegas JR, López-García E, Dallongeville J, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011; 32: 2143-2152.
27. Dallongeville J, Banegas JR, Tubach F, et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol. 2012; 19: 541-550.
28. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007; 14 Suppl 2: S1-113.
29. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24: 987-1003.
30. Paulsen MS, Sondergaard J, Reuther L, et al., Treatment of hypertension in general practice: a cross-sectional study of 5413 hypertensive patients. Fam Pract. 2011; 28: 599-607.
31. Horton ES. Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: results from large scale efficacy trials. Obesity (Silver Spring). 2009; 17 Suppl 3: S43-48.
32. Fleming P, Godwin M. Lifestyle interventions in primary care: systematic review of randomized controlled trials. Can Fam Physician. 2008; 54: 1706-1713.
33. Menotti A, Lanti M, Kafatos A, et al. The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and allcause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Study. J Hypertens. 2004; 22: 1683-1690.
34. Panagiotakos DB, Kromhout D, Menotti A, et al. The relation between pulse pressure and cardiovascular mortality in 12,763 middle-aged men from various parts of the world: a 25-year follow-up of the seven countries study. Arch Intern Med. 2005; 165: 2142-2147.
35. de Hollander EL, Bemelmans WJ, Boshuizen HC, et al. The association between waist circumference and risk of mortality considering body mass index in 65- to 74-year-olds: a metaanalysis of 29 cohorts involving more than 58 000 elderly persons. Int J Epidemiol. 2012; 41: 805-817.
36. Dudina A, Cooney MT, Bacquer DD, et al. Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil. 2011; 18: 731-742.
37. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol. 1992; 2: 23-28.
38. LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation. 1990; 81: 1721-1733.
39. Menotti A, Lanti M, Puddu PE, Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 2000; 84: 238-244.
40. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 24: 1601-1610.
41. Panagiotakos DB, Fitzgerald AP, Pitsavos C, Pipilis A, Graham I, Stefanadis C. Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project). Hellenic J Cardiol. 2007; 48: 55-63.
42. Chimonas T, Athyros VG, Ganotakis E, et al. Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome. Angiology. 2010; 61: 49-57.
43. Broedl UC, Geiss HC, Parhofer KG. Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy. J Gen Intern Med. 2003; 18: 190-195.
44. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol. 2009; 54: 1209-1227.
45. Zhang XF, Attia J, D'Este C, Yu XH, Wu XG. A risk score predicted coronary heart disease and stroke in a Chinese cohort. J Clin Epidemiol. 2005; 58: 951-958.